SCOPUS 정보 검색 플랫폼

European Journal of Clinical Pharmacology

Volumn 64, Issue 1, 2008, Pages 93-94

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam

(7) Tóth, Mária a Drabant, Sándor a Varga, Bálint a Végső, Gyula b Cseh, Anna a Szentpéteri, Imre a Klebovich, Imre b

a EGIS PHARMACEUTICALS LTD (Hungary)

b SEMMELWEIS UNIVERSITY (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CYTOCHROME P450 3A4; MIDAZOLAM; TACROLIMUS; TOFISOPAM;

AREA UNDER THE CURVE; CAPILLARY GAS CHROMATOGRAPHY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; LETTER; MALE; MASS SPECTROMETRY; MORNING DOSAGE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 38049026400 PISSN: 00316970 EISSN: None Source Type: Journal
DOI: 10.1007/s00228-007-0397-y Document Type: Letter

Times cited : (4)

References (8)

1
- 0029586398
- Clinical pharmacokinetics of tacrolimus
- Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichel J, Lever J, Burckart G, Starzl T (1995) Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29:404-430
- (1995) Clin Pharmacokinet , vol.29 , pp. 404-430
- Venkataramanan, R.¹ Swaminathan, A.² Prasad, T.³ Jain, A.⁴ Zuckerman, S.⁵ Warty, V.⁶ McMichel, J.⁷ Lever, J.⁸ Burckart, G.⁹ Starzl, T.¹⁰

2
- 24944464940
- Contribution of human hepatic cytochrrome P450 isoforms to the metabolism of psychotropic drugs
- Niwa T, Shiraga T, Ishi I, Kagayama A, Tagaki A (2005) Contribution of human hepatic cytochrrome P450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull 28:1711-1716
- (2005) Biol Pharm Bull , vol.28 , pp. 1711-1716
- Niwa, T.¹ Shiraga, T.² Ishi, I.³ Kagayama, A.⁴ Tagaki, A.⁵

3
- 29944438667
- Effect of tofisopam on human recombinant 3A4 supersome
- Tóth M, Bajnógel J, Egyed A, Drabant S, Tömlo J, Klebovich I (2005) Effect of tofisopam on human recombinant 3A4 supersome. Acta Pharm Hung 75:195-198
- (2005) Acta Pharm Hung , vol.75 , pp. 195-198
- Tóth, M.¹ Bajnógel, J.² Egyed, A.³ Drabant, S.⁴ Tömlo, J.⁵ Klebovich, I.⁶

4
- 33745713162
- Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cytochrome P450-3A4 probe drug alprazolam
- Drabant S, Tóth M, Bereczki A, Bajnógel J, Tömlo J, Klebovich I (2006) Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cytochrome P450-3A4 probe drug alprazolam. Eur J Clin Pharmacol 62:587-588
- (2006) Eur J Clin Pharmacol , vol.62 , pp. 587-588
- Drabant, S.¹ Tóth, M.² Bereczki, A.³ Bajnógel, J.⁴ Tömlo, J.⁵ Klebovich, I.⁶

5
- 0036360906
- Drug interaction with tacrolimus
- van Gelder T (2002) Drug interaction with tacrolimus. Drug Safety 25:707-712
- (2002) Drug Safety , vol.25 , pp. 707-712
- Van Gelder, T.¹

6
- 0030015297
- Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism
- Thummel KE, O'Shea D et al (1996) Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 59:491-502
- (1996) Clin Pharmacol Ther , vol.59 , pp. 491-502
- Thummel, K.E.¹ O'Shea, D.²

7
- 0024336508
- Extrahepatic metabolism of midazolam
- Park GR, Manara AR, Dawling S (1989) Extrahepatic metabolism of midazolam. Br J Clin Pharmacol 27:634-637
- (1989) Br J Clin Pharmacol , vol.27 , pp. 634-637
- Park, G.R.¹ Manara, A.R.² Dawling, S.³

8
- 34247178491
- Preliminary Concept Paper.
- Preliminary Concept Paper. "Drug Interaction Studies_Study Design, Data Analysis, and Implications for Dosing and Labelling". www.fda.gov/cder/guidance/6695dft.htm
- Drug Interaction Studies_Study Design, Data Analysis, and Implications for Dosing and Labelling

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.